Evolus (NASDAQ:EOLS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Evolus (EOLS) operate in?

Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Evolus Stock (NASDAQ: EOLS) stock price, news, charts, stock research, profile.

Open	$10.84
Close	$10.85
Volume / Avg.	277.69K / 604.54K
Day Range	$10.64 - $10.96
52 Wk Range	9.80 - 17.82
Market Cap	$687.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	8.41%
Days to Cover	8.3

Recent News

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

Avi Kapoor

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.

Avi Kapoor

Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker

Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.84
Close	$10.85
Volume / Avg.	277.69K / 604.54K
Day Range	$10.64 - $10.96
52 Wk Range	9.80 - 17.82
Market Cap	$687.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	8.41%
Days to Cover	8.3

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Evolus (EOLS) stock?

You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.

View our list of the best stock brokerages

Who are Evolus (EOLS) competitors?

Other companies in Evolus’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Evolus (EOLS) stock?

Evolus has a consensus price target of $21.00.

What is the current price for Evolus (EOLS)?

The stock price for Evolus (NASDAQ: EOLS) is $10.85 last updated December 24, 2024 at 1:01 PM EST.

Does Evolus (EOLS) pay a dividend?

There are no upcoming dividends for Evolus.

When is Evolus (NASDAQ:EOLS) reporting earnings?

Evolus’s Q4 earnings are confirmed for Thursday, March 6, 2025.

Is Evolus (EOLS) going to split?

There is no upcoming split for Evolus.

What sector and industry does Evolus (EOLS) operate in?

Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Evolus

Evolus (EOLS) Forecast